Pepgen Inc (PEPG)

$6.66 +0.12 (1.83%)
Market Cap 449.61M
Revenue (ttm) 0.00
Net Income (ttm) -89.98M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 351,200
Avg Vol 691,524
Day's Range N/A - N/A
Shares Out 68.75M
Stochastic %K 80%
Beta 1.91
Analysts Strong Sell
Price Target $10.17

Company Profile

PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. Its lead product candidates comprise PGN-EDO51, an EDO peptide which is Phase 2 clinical trial to treat duchenne muscular dystrophy (DMD) patients that are amenable to an exon 51-skipping approach; PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type...

Industry: Biotechnology
Sector: Healthcare
Phone: 781 797 0979
Website: pepgen.com
Address:
321 Harrison Avenue, 8th Floor, Boston, United States
erevnon
erevnon Feb. 18 at 3:54 PM
Guggenheim maintains PepGen $PEPG at Buy and raises the price target from $6 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
optionsReasy
optionsReasy Feb. 18 at 12:05 AM
$PEPG holding up like a G. If this holds till Friday forgetttaboutit
0 · Reply
VoidGorilla
VoidGorilla Feb. 17 at 6:26 PM
$HXHX $KPTI $PEPG $VAL.X //\\
0 · Reply
VoidGorilla
VoidGorilla Feb. 17 at 4:10 PM
$VAL.X $GLXG $DHX $PEPG <><>
0 · Reply
optionsReasy
optionsReasy Feb. 17 at 12:52 PM
$PEPG how did I just see this lol
0 · Reply
Stonky_Mcprofitface
Stonky_Mcprofitface Feb. 17 at 12:31 PM
$PEPG I’d be careful here.
0 · Reply
StockScanners
StockScanners Feb. 17 at 1:10 AM
$PEPG reached 7.14 lets go team
0 · Reply
Sw1ngb0t
Sw1ngb0t Feb. 12 at 9:23 PM
$PEPG $7.98+
0 · Reply
optionsReasy
optionsReasy Feb. 12 at 7:38 PM
$PEPG if this hits 10 before Feb 20th I’ll be very sad lol #coveredcalls lol
0 · Reply
potrero
potrero Feb. 12 at 6:40 PM
$PEPG
0 · Reply
Latest News on PEPG
PepGen Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Business and Legal Officer

Dec 9, 2025, 7:00 AM EST - 2 months ago

PepGen Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Business and Legal Officer

PepGen Appoints Joseph Vittiglio, Esq., as Chief Business and Legal Officer

Dec 8, 2025, 7:00 AM EST - 2 months ago

PepGen Appoints Joseph Vittiglio, Esq., as Chief Business and Legal Officer

PepGen Announces Issuance of U.S. Patent for Proprietary PGN-EDODM1 Molecule

Nov 12, 2025, 7:05 AM EST - 3 months ago

PepGen Announces Issuance of U.S. Patent for Proprietary PGN-EDODM1 Molecule

PepGen Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights

Nov 12, 2025, 7:00 AM EST - 3 months ago

PepGen Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights

PepGen to Participate in Upcoming Investor Conferences

Nov 3, 2025, 7:00 AM EST - 3 months ago

PepGen to Participate in Upcoming Investor Conferences

PepGen: DMD Discontinued, Ways To Go With DM1

Oct 7, 2025, 6:38 PM EDT - 4 months ago

PepGen: DMD Discontinued, Ways To Go With DM1

PepGen Announces Oral Presentations at the 30th Annual International Congress of the World Muscle Society

Oct 2, 2025, 7:00 AM EDT - 5 months ago

PepGen Announces Oral Presentations at the 30th Annual International Congress of the World Muscle Society

PepGen Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters' Option to Purchase Additional Shares

Sep 26, 2025, 4:01 PM EDT - 5 months ago

PepGen Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters' Option to Purchase Additional Shares

PepGen Reports Highest Splicing Correction In Dystrophy Patients, Stock Doubles

Sep 25, 2025, 9:46 AM EDT - 5 months ago

PepGen Reports Highest Splicing Correction In Dystrophy Patients, Stock Doubles

PepGen Announces Pricing of $100 Million Public Offering

Sep 24, 2025, 10:51 PM EDT - 5 months ago

PepGen Announces Pricing of $100 Million Public Offering

PepGen Announces Proposed Public Offering

Sep 24, 2025, 4:21 PM EDT - 5 months ago

PepGen Announces Proposed Public Offering

PepGen Announces Highest Mean Splicing Correction Reported in DM1 Patients

Sep 24, 2025, 4:16 PM EDT - 5 months ago

PepGen Announces Highest Mean Splicing Correction Reported in DM1 Patients

PepGen Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

Aug 7, 2025, 8:00 AM EDT - 7 months ago

PepGen Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PepGen

Jul 30, 2025, 5:41 PM EDT - 7 months ago

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PepGen

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PepGen

Jul 29, 2025, 10:33 AM EDT - 7 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PepGen

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PepGen

Jul 23, 2025, 11:22 AM EDT - 7 months ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PepGen

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of August 8, 2025 in PepGen Inc. Lawsuit - PEPG

Jun 23, 2025, 9:00 AM EDT - 8 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of August 8, 2025 in PepGen Inc. Lawsuit - PEPG

Shareholders who lost money on PepGen Inc. (NASDAQ: PEPG) Should Contact Wolf Haldenstein

Jun 16, 2025, 10:39 AM EDT - 8 months ago

Shareholders who lost money on PepGen Inc. (NASDAQ: PEPG) Should Contact Wolf Haldenstein

PEPGEN INC. (NASDAQ: PEPG) INVESTOR ALERT Investors With Large Losses in PepGen Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

Jun 10, 2025, 10:44 AM EDT - 9 months ago

PEPGEN INC. (NASDAQ: PEPG) INVESTOR ALERT Investors With Large Losses in PepGen Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

PepGen Abandons Duchenne Program, Shifts Spotlight To Another Rare Disease Candidate

May 29, 2025, 9:19 AM EDT - 9 months ago

PepGen Abandons Duchenne Program, Shifts Spotlight To Another Rare Disease Candidate

PepGen to discontinue development of experimental Duchenne therapy; shares drop

May 28, 2025, 6:21 PM EDT - 9 months ago

PepGen to discontinue development of experimental Duchenne therapy; shares drop

PepGen to Focus on Development of Promising DM1 Program Following 10 mg/kg PGN-EDO51 Update

May 28, 2025, 4:05 PM EDT - 9 months ago

PepGen to Focus on Development of Promising DM1 Program Following 10 mg/kg PGN-EDO51 Update

PepGen Appoints Kasra Kasraian, PhD, as Chief Technology Officer

May 20, 2025, 7:00 AM EDT - 9 months ago

PepGen Appoints Kasra Kasraian, PhD, as Chief Technology Officer

PepGen Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

May 8, 2025, 8:00 AM EDT - 10 months ago

PepGen Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

PepGen to Present at the 24th Annual Needham Virtual Healthcare Conference

Apr 2, 2025, 4:05 PM EDT - 11 months ago

PepGen to Present at the 24th Annual Needham Virtual Healthcare Conference

PepGen Announces Appointment of Two New Directors to its Board

Mar 31, 2025, 4:05 PM EDT - 11 months ago

PepGen Announces Appointment of Two New Directors to its Board

PepGen Announces Presentations at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference

Mar 10, 2025, 4:05 PM EDT - 1 year ago

PepGen Announces Presentations at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference

PepGen To Voluntarily Pause Mid-Stage Duchenne Muscular Dystrophy Study, Stock Falls

Mar 4, 2025, 1:41 PM EST - 1 year ago

PepGen To Voluntarily Pause Mid-Stage Duchenne Muscular Dystrophy Study, Stock Falls

erevnon
erevnon Feb. 18 at 3:54 PM
Guggenheim maintains PepGen $PEPG at Buy and raises the price target from $6 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
optionsReasy
optionsReasy Feb. 18 at 12:05 AM
$PEPG holding up like a G. If this holds till Friday forgetttaboutit
0 · Reply
VoidGorilla
VoidGorilla Feb. 17 at 6:26 PM
$HXHX $KPTI $PEPG $VAL.X //\\
0 · Reply
VoidGorilla
VoidGorilla Feb. 17 at 4:10 PM
$VAL.X $GLXG $DHX $PEPG <><>
0 · Reply
optionsReasy
optionsReasy Feb. 17 at 12:52 PM
$PEPG how did I just see this lol
0 · Reply
Stonky_Mcprofitface
Stonky_Mcprofitface Feb. 17 at 12:31 PM
$PEPG I’d be careful here.
0 · Reply
StockScanners
StockScanners Feb. 17 at 1:10 AM
$PEPG reached 7.14 lets go team
0 · Reply
Sw1ngb0t
Sw1ngb0t Feb. 12 at 9:23 PM
$PEPG $7.98+
0 · Reply
optionsReasy
optionsReasy Feb. 12 at 7:38 PM
$PEPG if this hits 10 before Feb 20th I’ll be very sad lol #coveredcalls lol
0 · Reply
potrero
potrero Feb. 12 at 6:40 PM
$PEPG
0 · Reply
topstockalerts
topstockalerts Feb. 12 at 4:00 PM
Top Gainers PT2 $JZXN $FLX $PEPG $SSII $VCICW
0 · Reply
topstockalerts
topstockalerts Feb. 12 at 3:34 PM
$PEPG Heating up again after a brief pause 🔥. Buyers are back and pushing it higher. This could turn into another strong leg.
0 · Reply
optionsReasy
optionsReasy Feb. 12 at 3:33 PM
$PEPG 20% and it’s still not done 💰 7.50 if 6.50 holds
0 · Reply
optionsReasy
optionsReasy Feb. 12 at 2:40 PM
$PEPG send it 😎
1 · Reply
potrero
potrero Feb. 11 at 8:45 PM
$PEPG
0 · Reply
KristyZediker521
KristyZediker521 Feb. 11 at 2:09 PM
$PEPG PepGen; biotech focused on neuromuscular gene therapies; early-stage pipeline with high technical risk; Duchenne MD space is competitive and binary.
0 · Reply
StockScanners
StockScanners Feb. 11 at 5:22 AM
$PEPG keep watch if this holds above 5.30
0 · Reply
optionsReasy
optionsReasy Feb. 10 at 10:20 PM
$PEPG smart money keeps buying every dip
0 · Reply
optionsReasy
optionsReasy Feb. 10 at 5:18 PM
$PEPG it’s on a roll 🔥
1 · Reply
Stockboi_
Stockboi_ Feb. 10 at 3:59 PM
$PEPG 🙌
1 · Reply
optionsReasy
optionsReasy Feb. 10 at 3:56 PM
$PEPG up 14%!!! 💰 🤑
1 · Reply
Stockboi_
Stockboi_ Feb. 10 at 1:52 AM
$PEPG 🏃 looking good again if support holds
0 · Reply